Your browser doesn't support javascript.
loading
[Prospective randomized trial comparing 1/2 FAM (5-fluorouracil (5-FU) + adriamycin + mitomycin C) versus palliative therapy for the treatment of unresectable pancreatic and biliary tract carcinomas (the 2nd trial in non-resectable patients). Japanese Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract].
Takada, T; Kato, H; Matsushiro, T; Nimura, Y; Nagakawa, T; Nakayama, T; Yamauchi, H; Ogata, Y; Shimada, H; Miyakawa, S; Yamaguchi, A; Sakoda, K; Yasuda, H; Tsukada, K; Yoshida, K; Ashida, H; Ishikawa, Y; Kotoura, Y; Kinoshita, H; Kajiwara, T; Watanabe, G; Uchimura, M; Funabiki, T; Ikeda, S; Okada, S.
Affiliation
  • Takada T; 1st Dept. of Surgery, Teikyo University, Japan.
Gan To Kagaku Ryoho ; 23(6): 707-14, 1996 May.
Article in Ja | MEDLINE | ID: mdl-8645022
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Palliative Care / Pancreatic Neoplasms / Biliary Tract Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Country/Region as subject: Asia Language: Ja Journal: Gan To Kagaku Ryoho Year: 1996 Type: Article Affiliation country: Japan
Search on Google
Add to My VHL
Print
XML
PubMed Links

Database: MEDLINE Main subject: Palliative Care / Pancreatic Neoplasms / Biliary Tract Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Country/Region as subject: Asia Language: Ja Journal: Gan To Kagaku Ryoho Year: 1996 Type: Article Affiliation country: Japan